Works by Malcolm Tingle
Results: 29
Sinonasal and gastrointestinal bacterial composition and abundance are stable after 1 week of once‐daily oral antibiotic treatment for chronic rhinosinusitis.
- Published in:
- International Forum of Allergy & Rhinology, 2021, v. 11, n. 9, p. 1355, doi. 10.1002/alr.22799
- By:
- Publication type:
- Article
Metabolic interactions with piperazine-based 'party pill' drugs.
- Published in:
- Journal of Pharmacy & Pharmacology, 2009, v. 61, n. 7, p. 877, doi. 10.1211/jpp/61.07.0006
- By:
- Publication type:
- Article
Reversible binding of the novel anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid to plasma proteins and its distribution into blood cells in various species.
- Published in:
- Journal of Pharmacy & Pharmacology, 2001, v. 53, n. 4, p. 463, doi. 10.1211/0022357011775758
- By:
- Publication type:
- Article
CYP-catalysed cycling of clozapine and clozapine-N-oxide promotes the generation of reactive oxygen species in vitro.
- Published in:
- Xenobiotica, 2024, v. 54, n. 1, p. 26, doi. 10.1080/00498254.2023.2294473
- By:
- Publication type:
- Article
Oral antibiotics used in the treatment of chronic rhinosinusitis have limited penetration into the sinonasal mucosa: a randomized trial.
- Published in:
- Xenobiotica, 2020, v. 50, n. 12, p. 1443, doi. 10.1080/00498254.2020.1814973
- By:
- Publication type:
- Article
Ascending single dose pharmacokinetics of cytisine in healthy adult smokers.
- Published in:
- Xenobiotica, 2019, v. 49, n. 11, p. 1332, doi. 10.1080/00498254.2018.1557760
- By:
- Publication type:
- Article
Plasma concentrations of cytisine, a commercially available plant-based alkaloid, in healthy adult smokers taking recommended doses for smoking cessation.
- Published in:
- Xenobiotica, 2018, v. 48, n. 12, p. 1245, doi. 10.1080/00498254.2017.1409916
- By:
- Publication type:
- Article
Indirect regulation of CYP2C19 gene expression via DNA methylation.
- Published in:
- Xenobiotica, 2018, v. 48, n. 8, p. 781, doi. 10.1080/00498254.2017.1372648
- By:
- Publication type:
- Article
The combined impact of CYP2C19 and CYP2B6 pharmacogenetics on cyclophosphamide bioactivation N. A. Helsby et al. Cyclophosphamide activation by CYP2C19 and CYP2B6.
- Published in:
- British Journal of Clinical Pharmacology, 2010, v. 70, n. 6, p. 844, doi. 10.1111/j.1365-2125.2010.03789.x
- By:
- Publication type:
- Article
Effects of anticancer drugs on the metabolism of the anticancer drug 5,6-dimethylxanthenone-4-acetic (DMXAA) by human liver microsomes.
- Published in:
- British Journal of Clinical Pharmacology, 2001, v. 52, n. 2, p. 129, doi. 10.1046/j.0306-5251.2001.01438.x
- By:
- Publication type:
- Article
Contrasting effects of acute and chronic dietary exposure to 2-amino-3-methyl-imidazo[4,5-f]quinoline (IQ) on xenobiotic metabolising enzymes in the male Fischer 344 Rat: implications for chemoprevention studies.
- Published in:
- European Journal of Nutrition, 2001, v. 40, n. 1, p. 39, doi. 10.1007/PL00007384
- By:
- Publication type:
- Article
The importance of correct assignment of CYP2B6 genetic variants with respect to cyclophosphamide metabolizer status.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 4, p. 383, doi. 10.1002/ajh.21987
- By:
- Publication type:
- Article
A pharmacokinetic framework describing antibiotic adsorption to cardiopulmonary bypass devices.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 8, p. 1409, doi. 10.1002/psp4.13180
- By:
- Publication type:
- Article
Circulating microRNA as biomarkers of clozapine-induced cardiotoxicity.
- Published in:
- Biomarkers, 2020, v. 25, n. 1, p. 76, doi. 10.1080/1354750X.2019.1693631
- By:
- Publication type:
- Article
Ethnic disparity in clozapine dosing and cardiotoxicity in New Zealand.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Pharmacokinetic Properties of Adenosine Amine Congener in Cochlear Perilymph after Systemic Administration.
- Published in:
- BioMed Research International, 2017, v. 2017, p. 1, doi. 10.1155/2017/8091462
- By:
- Publication type:
- Article
Varenicline improves motor and cognitive symptoms in early Huntington's disease.
- Published in:
- Neuropsychiatric Disease & Treatment, 2016, v. 12, p. 2381, doi. 10.2147/NDT.S111083
- By:
- Publication type:
- Article
Use of a metabolic inhibitor to reduce dapsone-dependent haematological toxicity.
- Published in:
- Drug Development Research, 1992, v. 25, n. 1, p. 1, doi. 10.1002/ddr.430250102
- By:
- Publication type:
- Article
Satraplatin activation by haemoglobin, cytochrome C and liver microsomes in vitro.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 4, p. 483, doi. 10.1007/s00280-005-0069-5
- By:
- Publication type:
- Article
Rapid biotransformation of satraplatin by human red blood cells in vitro.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 1, p. 9, doi. 10.1007/s00280-002-0462-2
- By:
- Publication type:
- Article
Gender differences in the metabolism and pharmacokinetics of the experimental anticancer agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2002, v. 49, n. 2, p. 126, doi. 10.1007/s00280-001-0383-5
- By:
- Publication type:
- Article
A difference between the rat and mouse in the pharmacokinetic interaction of 5,6-dimethylxanthenone-4-acetic acid with thalidomide.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2001, v. 47, n. 6, p. 541, doi. 10.1007/s002800100285
- By:
- Publication type:
- Article
In vitro and in vivo kinetic interactions of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid with thalidomide and diclofenac.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2001, v. 47, n. 4, p. 319, doi. 10.1007/s002800000249
- By:
- Publication type:
- Article
COMPARATIVE PROTEIN BINDING, STABILITY AND DEGRADATION OF SATRAPLATIN, JM118 AND CISPLATIN IN HUMAN PLASMA IN VITRO.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2008, v. 35, n. 12, p. 1440, doi. 10.1111/j.1440-1681.2008.05017.x
- By:
- Publication type:
- Article
Pharmacokinetics of cytisine, an α<sub>4</sub>β<sub>2</sub> nicotinic receptor partial agonist, in healthy smokers following a single dose.
- Published in:
- Drug Testing & Analysis, 2015, v. 7, n. 6, p. 475, doi. 10.1002/dta.1707
- By:
- Publication type:
- Article
Adenosine Amine Congener as a Cochlear Rescue Agent.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/841489
- By:
- Publication type:
- Article
Metabolizing enzyme localization and activities in the first trimester human placenta: the effect of maternal and gestational age, smoking and alcohol consumption.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Validation of an LC–MS Method for the Detection and Quantification of BZP and TFMPP and their Hydroxylated Metabolites in Human Plasma and its Application to the Pharmacokinetic Study of TFMPP in Humans.
- Published in:
- Journal of Forensic Sciences, 2010, v. 55, n. 5, p. 1311, doi. 10.1111/j.1556-4029.2010.01457.x
- By:
- Publication type:
- Article
Comparison of Sinus Deposition from an Aqueous Nasal Spray and Pressurised MDI in a Post-Endoscopic Sinus Surgery Nasal Replica.
- Published in:
- Pharmaceutical Research, 2022, v. 39, n. 2, p. 317, doi. 10.1007/s11095-021-03129-2
- By:
- Publication type:
- Article